Home › Funds › Renaissance Technologies › VRTX
Renaissance Technologies position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)320.01K sh
Reported value held$158.96M
Portfolio Weight0.22%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.89M | $343.10M | New |
| Q4 2021 | 1.63M | $357.26M | Reduce |
| Q1 2022 | 1.71M | $445.57M | Add |
| Q2 2022 | 1.76M | $496.28M | Add |
| Q3 2022 | 2.14M | $619.29M | Add |
| Q4 2022 | 2.25M | $648.82K | Add |
| Q1 2023 | 1.40M | $440.38K | Reduce |
| Q2 2023 | 1.27M | $447.69K | Reduce |
| Q3 2023 | 1.66M | $578.67K | Add |
| Q4 2023 | 1.59M | $647.64K | Reduce |
| Q1 2024 | 1.58M | $660.66K | Reduce |
| Q2 2024 | 1.57M | $734.20M | Reduce |
| Q3 2024 | 1.63M | $758.77M | Add |
| Q4 2024 | 1.40M | $562.66M | Reduce |
| Q1 2025 | 1.17M | $568.00M | Reduce |
| Q2 2025 | 1.00M | $447.38M | Reduce |
| Q3 2025 | 735.89K | $288.20M | Reduce |
| Q4 2025 | 505.05K | $228.97M | Reduce |
| Q1 2026 | 421.69K | $188.30M | Reduce |
| Q2 2026 | 320.01K | $158.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026